US7613301099 - RVNC - A1XD3D (XNMS)
REVANCE THERAPEUTICSCS INC Action
3,06 USD
Cours actuels de REVANCE THERAPEUTICSCS INC
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière | Variation journalière % |
---|---|---|---|---|---|---|
NASDAQ |
RVNC
|
USD
|
24.12.2024 14:01
|
3,06 USD
| 3,07 USD | -0,29 % |
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
-0,29 % | -0,29 % | -17,93 % | -42,94 % | 15,08 % | -64,28 % | -81,16 % |
Firmenprofil zu REVANCE THERAPEUTICSCS INC Aktie
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing DaxibotulinumtoxinA in preclinical trial for the treatment of migraine, as well as a topical program for various indications; and OnabotulinumtoxinA, a biosimilar to BOTOX. The company has a collaboration and license agreement with Viatris Inc. to develop, manufacture, and commercialize onabotulinumtoxinA. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Investierte Fonds
Folgende Fonds haben in investiert: REVANCE THERAPEUTICSCS INC investiert:
Fonds | Vol. in Mio 64,39 | Anteil (%) 0,15 % |
Unternehmensdaten zur REVANCE THERAPEUTICSCS INC Aktie
Name REVANCE THERAPEUTICSCS INC
Firma Revance Therapeutics, Inc.
Symbol RVNC
Website https://www.revance.com
Heimatbörse
NASDAQ/NMS (GLOBAL MARKET)
WKN A1XD3D
ISIN US7613301099
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Mark J. Foley
Marktkapitalisierung 686 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,6 T
Adresse 1222 Demonbreun Street, 37203 Nashville
IPO Datum 2014-02-06
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | RTI.F |
NASDAQ | RVNC |
Weitere Aktien
Investoren die REVANCE THERAPEUTICSCS INC die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.